Evaluation of the Outcomes of Laparoscopic Sleeve Gastrectomy with Cruroplasty Versus Roux-en-Y Gastric Bypass in Morbid Obese Patients with Gastro-Esophageal Reflux Disease | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2025, Issue 4, April 2025, Page 175-181 PDF (502.96 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/aimj.2025.446521 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Taher Kamel Ali; Mohamed Fathy Sharaf; Mohamed Mostafa Tag El-din | ||||
| General Surgery, Faculty of Medicine for Boys, Al-Azhar University, Cairo, Egypt | ||||
| Abstract | ||||
| Background: Obesity is the number one health risk facing people today, according to the World Health Organisation. An enormous morbidity and death burden is being caused by the increasing incidence of obesity. Aim and objectives: To evaluate the efficacy of laparoscopic Roux-en-Y gastric bypass (LRNYGB) and laparoscopic sleeve gastrectomy (LSG) with cruroplasty and other procedures in treating obesity-related GERD symptoms and promoting weight loss in patients with the condition at one year post-operatively. Subjects and methods: From January 2022 through January 2024, fifty severely obese patients with GERD grade (A) or (B) diagnosed by endoscopy at the surgery department of Al-Azhar University Hospitals participated in a randomized controlled clinical trial with follow-up at1,3,6, and 12 months after surgery. Results: There was a statistically significant difference between the sleeve group and the Roux-en-Y group at1,3,6, and 12 months (p=0.001, 0.024, 0.031, and 0.012, respectively) compared to reflux symptoms. Conclusion: While the weight loss and GERD symptom and severity improvements achieved by LSG with cruroplasty are good, they pale in comparison to those achieved by LRYGB during the one-year post-operative follow-up period. | ||||
| Keywords | ||||
| Laparoscopic sleeve gastrectomy; Roux-en-Y gastric bypass; Gastro-esophageal reflux | ||||
|
Statistics Article View: 7 |
||||
